Invasive Breast Carcinoma Terminated Phase 2 Trials for Capecitabine (DB01101)

Also known as: Invasive carcinoma of breast / Breast cancer invasive NOS

IndicationStatusPhase
DBCOND0031787 (Invasive Breast Carcinoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00148720Capecitabine in Women With Operable Breast CancerTreatment